healthy individuals
Conditions
Interventions
Ingestion of study food for 4 weeks
Ingestion of control food substance for 4 weeks
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Subjects of men and women aged 20 to 80 (2) Subjects who are tired on a daily basis (3) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
Exclusion criteria
Exclusion criteria: (1) Subjects with a history of liver disease, renal disease, digestive system disease, heart disease, respiratory disease, peripheral angiopathy, and other diseases that may affect the results of this study, or subjects with a history of surgery (2) Subjects with diseases currently being treated (3) Subjects who have been diagnosed with psychiatric disorders such as chronic insomnia, depression, anxiety disorders, and schizophrenia (4) Subjects with food and drug allergies (5) Subjects on a diet (6) Subjects with irregular lives (7) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (8) Subjects who are continuously taking medicines (including OTC and prescription medicines) (9) Subjects taking excessive alcohol intake (10) Subjects who cannot stop drinking from the day before the test to the day of the test (11) Pregnant, lactating, or prospective pregnant or lactating subjects during the study period (12) Subjects who are participating in or will participate in other clinical trials at the start of this study, and within 4 weeks after the end of the study. (13) Other subjects judged by the investigator to be inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CFS (Chalder Fatigue Scale) Fatigue VAS QOLVAS Athens Insomnia Scale OSA sleep questionnaire Urine frequency | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed